The Clinical Innovation Platform (CLIP), powered by National Bank, is pleased to announce MISO Chip Inc as our newest member.
MISO Chip is a Quebec-based start-up and a Polytechnique Montreal and CRCHUM spin-off founded in 2019 to commercialize a new tumor-on-chip platform for drug development and personalized cancer care. Today, the company leverages its technology to help biotech and pharmaceutical companies with their preclinical validation.
With CLIP support, MISO Chip will continue its development of novel assays for drug development using its patient-derived tumor explant platform.